Aethlon Medical Inc financial data

Symbol
AEMD on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
11555 Sorrento Valley Road, Suite 203, San Diego, CA
State of incorporation
NV
Fiscal year end
March 31
Former names
BISHOP EQUITIES INC (to 3/13/2000)
Latest financial report
10-Q - Q4 2024 - Feb 12, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 346 % -47.6%
Debt-to-equity 41.1 % +80.9%
Return On Equity -71.7 % -46.6%
Return On Assets -109 % -26%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 14.5M shares +452%
Common Stock, Shares, Outstanding 14M shares +439%
Entity Public Float 5.5M USD -58.3%
Common Stock, Value, Issued 14K USD +439%
Weighted Average Number of Shares Outstanding, Basic 14M shares +455%
Weighted Average Number of Shares Outstanding, Diluted 14M shares +455%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 574K USD +95.2%
Research and Development Expense 1.54M USD -35.4%
General and Administrative Expense 3.29M USD -17%
Operating Income (Loss) -9.82M USD +22.2%
Net Income (Loss) Attributable to Parent -9.56M USD +22%
Earnings Per Share, Basic -1.59 USD/shares +75.7%
Earnings Per Share, Diluted -1.59 USD/shares +75.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 4.83M USD -39.5%
Cash, Cash Equivalents, and Short-term Investments 250K USD
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD -100%
Assets, Current 4.97M USD -39.8%
Property, Plant and Equipment, Net 762K USD -31.6%
Operating Lease, Right-of-Use Asset 673K USD -29.2%
Assets 6.53M USD -37.5%
Accounts Payable, Current 611K USD -11.9%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 1.77M USD -15.6%
Operating Lease, Liability, Noncurrent 418K USD -42.4%
Liabilities 2.19M USD -22.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax -17K USD -952%
Retained Earnings (Accumulated Deficit) -162M USD -6.28%
Stockholders' Equity Attributable to Parent 4.33M USD -43.1%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 5.77M USD -61.7%
Liabilities and Equity 6.53M USD -37.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.75M USD +29.6%
Net Cash Provided by (Used in) Financing Activities 5.38M USD +399%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 60M shares 0%
Common Stock, Shares, Issued 14M shares +439%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3.63M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 4.91M USD -39%
Deferred Tax Assets, Valuation Allowance 33.3M USD +10.8%
Deferred Tax Assets, Gross 33.3M USD +10.8%
Operating Lease, Liability 725K USD
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid 1M USD -23.9%
Property, Plant and Equipment, Gross 1.11M USD +12.4%
Operating Lease, Liability, Current 307K USD +7.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 333K USD +2.98%
Lessee, Operating Lease, Liability, to be Paid, Year One 324K USD +2.96%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 60.3K USD -43.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 343K USD +2.97%
Deferred Tax Assets, Operating Loss Carryforwards 26.9M USD +11.5%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 343K USD
Additional Paid in Capital 166M USD +3.94%
Depreciation, Depletion and Amortization 86.1K USD -4.72%
Deferred Tax Assets, Net of Valuation Allowance 0 USD